Mg Magnesiumsulfatheptahydrat

Magnesium sulfate heptahydrate, the active ingredient in Mg Magnesiumsulfatheptahydrat, is a magnesium salt presented as an injectable solution for intramuscular and intravenous use. It addresses magnesium deficiency and is employed in the management of eclampsia, severe cardiac arrhythmias, and asthma exacerbations.

GNH USA supplies Mg Magnesiumsulfatheptahydrat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Magnesium sulfate heptahydrate is used in several electrolyte‑related and cardiovascular conditions: - Magnesium deficiency: restores normal serum magnesium concentrations. - Eclampsia/preeclampsia: prevents and treats seizures in pregnant patients. - Severe cardiac arrhythmias (e.g., torsades de pointes): stabilises cardiac electrical activity. - Bronchial asthma exacerbations: promotes bronchodilation and reduces airway hyper‑responsiveness.

Adverse reactions may vary with dose and route of administration.

Common Side Effects: - Flushing: sensation of warmth and redness. - Sweating: increased perspiration. - Nausea: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Hypotension: modest reduction in blood pressure. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort. - Cardiac arrest: loss of effective heart activity. - Severe hypotension: marked drop in blood pressure. - Hypermagnesemia: excessive serum magnesium causing neuromuscular weakness. - Anaphylaxis: acute allergic reaction. - Arrhythmia worsening: paradoxical cardiac rhythm disturbances.

Magnesium sulfate heptahydrate requires careful clinical monitoring. - Renal impairment: monitor serum magnesium and adjust dosing. - Cardiac disease: use cautiously in patients with conduction abnormalities. - Neuromuscular disorders: observe for increased muscle weakness. - Pregnancy: limited safety data; weigh maternal benefit against fetal risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate heptahydrate can alter the effects of several drugs.

Major Interactions (Avoid): - Calcium channel blockers: additive hypotensive effect. - Neuromuscular blocking agents: prolonged paralysis. - Potassium‑sparing diuretics: heightened risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: may enhance neuromuscular blockade. - ACE inhibitors: potential for increased hypotension. - Other magnesium‑containing products: cumulative magnesium load.